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ABSTRACT
Maintaining neurogenesis in growing tissues requires a tight balance
between progenitor cell proliferation and differentiation. In the
zebrafish retina, neuronal differentiation proceeds in two stages
with embryonic retinal progenitor cells (RPCs) of the central retina
accounting for the first rounds of differentiation, and stem cells from
the ciliary marginal zone (CMZ) being responsible for late
neurogenesis and growth of the eye. In this study, we analyse two
mutants with small eyes that display defects during both early and late
phases of retinal neurogenesis. Thesemutants carry lesions in gdf6a,
a gene encoding a BMP family member previously implicated in
dorsoventral patterning of the eye. We show that gdf6a mutant eyes
exhibit expanded retinoic acid (RA) signalling and demonstrate that
exogenous activation of this pathway in wild-type eyes inhibits retinal
growth, generating small eyes with a reduced CMZ and fewer
proliferating progenitors, similar to gdf6a mutants. We provide
evidence that RA regulates the timing of RPC differentiation by
promoting cell cycle exit. Furthermore, reducing RA signalling in
gdf6a mutants re-establishes appropriate timing of embryonic retinal
neurogenesis and restores putative stem and progenitor cell
populations in the CMZ. Together, our results support a model in
which dorsally expressed gdf6a limits RA pathway activity to control
the transition from proliferation to differentiation in the growing eye.
KEY WORDS: Retinoic acid, BMP, Gdf6a, Ciliary marginal zone,
Neurogenesis, Retinal stem cells, Zebrafish
INTRODUCTION
The balance between cell proliferation and differentiation is spatially
and temporally regulated during development, ensuring the
generation of tissues with the correct proportion of differentiated
cells (Schmidt et al., 2013; Urbán and Guillemot, 2014). In the
vertebrate retina, this process begins when retinal progenitor
cells (RPCs) successively exit the cell cycle to generate retinal
ganglion cells (RGCs), cone photoreceptors, interneurons, rod
photoreceptors and Müller glia (Cepko, 2014). This progression of
fate specification and the timing of neurogenic decisions require
cells to integrate intrinsic information and extrinsic signals (Cepko,
2014; Cerveny et al., 2012). Cell cycle regulators and a variety of
transcription factors are implicated in the cell-autonomous
progression from RPC to post-mitotic neuron, and secreted signals
can influence the transition from proliferation to differentiation
(Agathocleous and Harris, 2009; Bassett and Wallace, 2012).
In vertebrate eyes, neurogenesis proceeds in waves. In zebrafish,
neuronal differentiation spreads across the developing retina from a
ventronasal patch of RPCs cells adjacent to the optic stalk
(Rappaport, 2006). This spread of neurogenesis is preceded by
comparable waves of expression of neurogenesis-related genes
including the proneural gene atoh7 and the paired-class cone-rod
homeobox gene crx (Masai et al., 2000; Shen and Raymond, 2004).
Differentiation of distinct neuronal types continues to propagate
circumferentially in successive waves, ultimately filling the
central retina by 48 hours post fertilisation (hpf). After this point,
neurogenesis occurs radially, with new neurons added to the eye in
successive rings from a peripheral area of the retina termed the
ciliary marginal zone (CMZ). The CMZ contains a stem cell niche
that allows continued growth and neurogenesis in the eye (Centanin
et al., 2011; Stenkamp, 2007).
Retinal neurogenesis occurs in a context where extrinsic signals
impart nasotemporal and dorsoventral (DV) positional identity to
newly generated neurons. In fish, the opposing actions of Fgf and
Shh initiate nasotemporal patterning (Hernandez-Bejarano et al.,
2015) whereas opposing Bmp and Hedgehog (Hh) signals (Yang,
2004) establish DV identities. For instance, Gdf6a (BMP13
homologue) and other BMPs are expressed in dorsal domains and
influence dorsal identity within the retina (French et al., 2009; Gosse
and Baier, 2009; Kruse-Bend et al., 2012; Williams et al., 2008).
Mutations in gdf6 genes have also been linked to other ocular
anomalies, including microphthalmia and coloboma (Asai-
Coakwell et al., 2013; den Hollander et al., 2010; French et al.,
2009). It is likely that the connection between axial patterning
signals and positional identity is maintained within the CMZ
as newly generated RGCs must integrate into existing circuitry
and project to topographically appropriate target regions within the
brain.
The RA signalling pathway also influences retinal development.
RA-synthesising enzymes are expressed predominantly in the
ventral retina and RA signalling is required for morphogenesis of
the ventral eye, including choroid fissure closure (Lupo et al., 2011;
Marsh-Armstrong et al., 1994). Expression of the RA synthesis
enzyme aldh1a3 is expanded dorsally in eyes of gdf6a morphantReceived 11 September 2015; Accepted 8 February 2016
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embryos (French et al., 2009) raising the possibility that interactions
between RA and Gdf6 signals occur during retinal development.
In this study, we sought to identify signals that regulate eye
growth and found that, in addition to their roles in DV patterning,
opposing Gdf6a and RA signals influence proliferation and
differentiation of RPCs. Through a forward genetic screen in
zebrafish, we identified two point mutations in gdf6a that lead to
reduction in size of the CMZ and subsequent small eye phenotypes.
These phenotypes are accompanied by an expansion of RA pathway
activity within the CMZ and precocious differentiation of RPCs.We
find that activating the RA pathway in wild-type eyes phenocopies
gdf6a mutants and that abrogation of RA signalling ameliorates the
gdf6amutant phenotype. Together, our results show that signals that
impart DV identity in the eye also regulate production of neurons
and retinal growth, revealing an unappreciated link between the
pathways that regulate patterning, proliferation, and stem/progenitor
cell maintenance in the developing eye.
RESULTS
gdf6amutants exhibit small eyes independent of apoptosis
Clutches of 72 hpf embryos from families of zebrafish carrying N-
ethyl-N-nitrosurea (ENU)-induced mutations (Valdivia et al., 2011)
were examined for ocular abnormalities, including microphthalmia.
We recovered two non-complementing, recessive mutations, u768
and u900, that when homozygous led to small eyes with ventrally
displaced lenses and, in some cases, coloboma (Fig. 1A). Although
both homozygous mutant phenotypes are fully penetrant, u900
mutants consistently display smaller eyes than u768 mutants
(Fig. S1D).
Both mutants carry lesions in gdf6a, a gene that is expressed
dorsally both in the developing retina (French et al., 2009; Gosse and
Baier, 2009) and the CMZ (Fig. 1B). Using bulk segregant analysis,
complementation testing, and sequencing, we identified u768 as a
missensemutation that results in the substitution of a threonine for an
absolutely conserved alanine at position 350 in the Gdf6a protein
(Fig. 1C). It is likely that this mutation generates a hypomorphic
Gdf6a protein. Sequencing identified u900 as a nonsense mutation
that converts the codon for Gln179 to a Stop (gdf6au900; Fig. 1C).
This mutation is predicted to generate a truncated protein lacking the
conserved carboxy-terminal signalling domain.
Previous studies have shown that loss of Gdf6a function is
associated with a transient wave of retinal apoptosis, suggesting that
Gdf6a is required for RPC survival (den Hollander et al., 2010;
Gosse and Baier, 2009). However, in gdf6au768mutants, the number
of apoptotic retinal cells between 24 and 36 hpf was similar to wild
type [gdf6au768=5.25±2.75 (mean±s.d.); wild-type siblings=3.4±
1.76; P=0.12; n=13 embryos of each genotype; Fig. 1D; Fig. S1A],
and retinal neurons appeared healthy, suggesting that cell death is
not the main driver of the small eye phenotype in this mutant.
Although gdf6au900 mutants displayed increased levels of retinal
apoptosis at around 30 hpf (Fig. S1B), blocking cell death with the
pan-caspase inhibitor Z-VAD-FMK reduced apoptotic levels but
did not rescue the subsequent small eye size, corroborating
previously published data (French et al., 2013) (Fig. S1C).
Functional studies have also implicated Gdf6a in patterning the
DV axis of the retina (French et al., 2009; Gosse and Baier, 2009;
Rissi et al., 1995). However, the u768 allele exhibits overtly normal
expression of DV markers at 24 hpf (Fig. 1E) suggesting that the
small eye phenotype arises in this mutant allele in the absence of
major defects in the establishment of axial patterning of the retina.
Together, these data suggest that a mechanism other than
programmed cell death and/or abnormal retinal patterning is
responsible for the small eye phenotype in gdf6a mutants.
The CMZ is reduced in gdf6amutants
As the CMZ is the primary source of new neurons and retinal growth
in fish larvae (Centanin et al., 2011; Raymond et al., 2006), we
examined expression of markers for subdomains of the CMZ in
Fig. 1. Small-eye phenotype in gdf6a mutants is
independent of programmed cell death in developing
retina. (A) Lateral views of wild-type and gdf6a mutants
showing small eyes. (B) Lateral view of dorsal gdf6a
expression (purple) in wild-type retina. (C) Domain
structure of Gdf6a protein indicating the N-terminal signal
peptide (amino acids 1-25, light blue), the furin protease
recognition site (amino acids 280-285, orange), and the
premature stop codon of gdf6au900 and missense
mutation (Ala350Thr) in gdf6au768 (asterisks). (D) Lateral
views of eyes of siblings (sib) and gdf6amutants. Similar
levels of TUNEL+ apoptotic cells (purple) are evident in
the gdf6au768 and sibling eyes at 30 hpf; most apoptotic
cells are in the lenses (arrows) and only few in the retinae
(arrowheads). TUNEL+ cells are undetectable in eyes of
either genotype by 2.5 dpf (lower panels). (E) Lateral
views of whole-mount eyes of 24 hpf gdf6au768 and
sibling embryos showing expression (purple) of markers
for dorsal (tbx5a) and ventral (vax2) retinal character.
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gdf6a mutants and found striking differences compared with wild-
type eyes as early as 2.5 days post fertilisation (dpf ). The most
peripheral col15a1b-expressing region, which contains presumptive
stem cells (Cerveny et al., 2010; Gonzalez-Nunez et al., 2010), is
reduced in gdf6au768 mutants with fewer col15a1b-positive cells in
the dorsal CMZ and virtually no col15a1b expression in the ventral
CMZ (Fig. 2A,B). Similarly, all other subdomains of this
germinal zone – proliferating progenitors (expressing ccnd1),
specified precursors (expressing the transcription factor atoh7),
and differentiating neurons (expressing the cyclin-dependent kinase
inhibitor cdkn1c) (Cerveny et al., 2010) – are reduced (Fig. 2C-H).
Similarly, altered patterns of gene expression were observed in the
CMZ of gdf6au900 eyes (Fig. S2).
To characterise themutant CMZs further, we examined expression
of Tg[vsx2:GFP]. vsx2 encodes a homeodomain transcription factor
expressed throughout the CMZ, in Müller glia and in a subset of
bipolar cells (Vitorino et al., 2009). Consistent with fewer cells
within the CMZ, we observed a smaller vsx2:GFP-expressing region
with only a few cells separating the retinal margin and atoh7:GAP-
RFP-expressing RGCs in 60 hpf gdf6au900mutant retinae (Fig. 2I,J).
Consistent with decreased growth from a smaller CMZ, gdf6a
mutant eyes contained fewer proliferative cells in both S phase
[marked by bromodeoxyuridine (BrdU) staining] and M phase
[marked by phospho-histone H3 (PH3) staining] of the cell
cycle (Fig. 2K-N) by 2.5 and 3 dpf (Fig. 2O; n=10 embryos for
each genotype). These findings indicate that reduced Gdf6a
function is correlated with decreased cell proliferation in the
CMZ.
To gauge expression levels of CMZ markers quantitatively, we
used real-time PCR (qPCR) in dissected mutant and wild-type
sibling larval retinae. Both mutant alleles show nearly identical
reduction in transcript levels of genes expressed in proliferating
progenitors (ccnd1) and committed precursors (e.g. atoh7)
(Fig. 2P). Although in situ hybridisation clearly shows fewer
col15a1b-positive cells, qPCR detected only a modest reduction in
transcript levels. Not all genes analysed, however, showed
decreased expression. A control gene, nr2f5, encoding a
transcriptional target of RA signalling (Love and Prince, 2012)
was elevated nearly 2.5-fold in gdf6a mutant eyes (Fig. 2P),
suggesting increased RA pathway activity.
Fig. 2. gdf6a mutants exhibit decreased expression of stem, progenitor and committed cell genes and reduced proliferation within the CMZ.
(A-H) Lateral views of whole-mount eyes from 3 dpf embryos (genotype bottom left) showing expression (purple) of various genes (indicated bottom left) in the
CMZ. (A,B) col15a1b, a marker of the peripheral putative stem cell compartment, is expressed in the sibling CMZ (A), but reduced in the dorsal and nearly absent
in the ventral CMZ of the gdf6au768 eye (B). (C,D) ccnd1 is highly expressed in proliferating progenitors of wild-type CMZs (C), but reduced in gdf6au768 mutant
eyes (D). (E-H) atoh7 and cdkn1c are expressed in committed precursors in wild-type CMZs (E,G) but in the gdf6au768 mutant eyes they are strongly
downregulated (F,H). (I,J) Transverse sections of 3 dpf sibling and gdf6au900 eyes carrying the vsx2:GFP (green) and atoh7:GAP-RFP (red) transgenes
highlighting a reduced CMZ in the gdf6au900mutant (white arrows). (K-N) Coronal sections immunostained for markers of proliferation (green; BrdU incorporation
in K,L or PH3 in M,N) and then counterstained with SYTOX Orange (red nuclei). (O) Graph showing numbers of PH3+ mitotic retinal cells in eyes of gdf6amutant
and sibling embryos. All PH3+ cells in ten whole-mount 60 hpf eyes were counted and graphed with standard error bars (95% confidence limits; Student’s t-test,
***P≤0.0004). (P) Graph showing real-time PCR quantification of gene expression changes of col15a1b, ccnd1, atoh7 and nr2f5 in 3 dpf dissected mutant and
wild-type retinas normalised to β-actin. Wild-type values for each gene were set to 1 and mutant fold changes were plotted relative to this value (±s.e.).
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gdf6amutants display RA pathway activity throughout
the peripheral CMZ
RA synthesis and target genes are ectopically activated throughout
the circumference of the peripheral-most compartment of the CMZ
of gdf6a mutants. Expression of two genes involved in RA
synthesis, retinol dehydrogenase (rdh10a) and a retinaldehyde
dehydrogenase (aldh1a3), is increased and expanded dorsally in the
gdf6au768 mutants (Fig. 3, top two rows). Consequently, and as
expected from qPCR experiments, nr2f5 is transcribed in more cells
of the presumptive CMZ (Fig. 3, middle row). Consistently,
gdf6au768mutants carrying an RA-responsive YFP transgene (Perz-
Edwards et al., 2001) exhibit expanded YFP expression in the
peripheral compartment of the CMZ (Fig. S3). Genes likely to limit
RA activity, such as the cytosolic RA binding protein crabp2a (Cai
et al., 2012) and the RA-degrading enzyme cyp26a1 (Isken et al.,
2008), are expressed in fewer cells in gdf6a mutant eyes (Fig. 3,
bottom two rows). Together, these data indicate that RA signalling
is enhanced in the CMZ of gdf6a mutants.
Enhanced RA pathway activity inhibits eye growth
We next asked whether excessive RA affects eye size. We first tested
whether all wild-type retinal progenitors respond to RA. Embryos
carrying the Tg[RARE:YFP] RA reporter transgene (Perz-Edwards
et al., 2001) were incubated with 13-cis RA, which can be locally
converted to all-trans RA by UV-driven photo-isomerisation to
activate the RA pathway (Xu et al., 2012). In 24-36 hpf wild-type
embryos, only ventral retinal cells activate the RA pathway reporter
transgene in the absence of exogenous all-trans RA (Fig. 4A). UV-
mediated activation of RA signalling, however, demonstrated
that most, if not all, RPCs are capable of responding to RA
(Fig. 4B). These data suggest that endogenous RA signalling is
spatially limited in the eye by RA availability, not cell competence
to respond to RA.
We next investigated whether pharmacological activation of the
RA pathway using AM580, a retinoic acid receptor alpha (RARα)
agonist (Gianni et al., 1996), affects eye development similarly
to gdf6a mutants. Embryos incubated in AM580 consistently
displayed smaller eyes with fewer PH3+ cells (Fig. 4I-M). Pairwise
t-test comparisons indicate that both gdf6a mutant and AM580-
treated embryos contain significantly fewer PH3+ cells than sibling
or DMSO-treated wild-type embryos (Fig. 4M). Permutation testing
of relative means (untreated gdf6au768 mutants/untreated siblings
and AM580-treated/DMSO-treated wild types) revealed that the
proportion of PH3+ cells in gdf6au768mutants relative to the number
of PH3+ cells in sibling eyes is not statistically different from the
proportion of PH3+ cells in AM580-treated eyes relative towild type
(P=0.56; Fig. S4). In addition, RA pathway upregulation is
correlated with reduced expression of markers for putative stem
and progenitor cells within the CMZ (Fig. 4C-H).
Inhibition of the RA pathway restores the CMZ in gdf6a
mutants
To evaluate the extent to which misregulation of RA pathway
activity contributes to the imbalance in proliferation and
differentiation, and subsequent growth of gdf6a mutant eyes, we
asked whether reducing RA pathway activity could restore the CMZ
in gdf6amutant retinae.When clutches of embryos from a gdf6au768
carrier in-cross were incubated with the panRAR inverse agonist
BMS493 (Germain et al., 2009), mutant eyes contained more cells
expressing col15a1b, ccnd1 and atoh7 in the peripheral retina
(Fig. 5A-F). We also quantified transcript levels for CMZ markers
in BMS493-treated eyes relative to DMSO-treated eyes and
confirmed in situ hybridisation data that ccnd1 and atoh7 levels
were increased (Fig. 5G). Because changes in col15a1b detected by
qPCR were modest, we measured the percentage area of col15a1b-
positive cells in control and BMS-treated eyes and found that treated
eyes contained a nearly 40% larger col15a1b-positive area than did
controls (Fig. S5C). Sibling eyes with the same treatment exhibited
a noticeable expansion of col15a1b in the ventral retina (Fig. S5B).
Together, these data suggest that RA limits expression of CMZ
Fig. 3. Expression of genes encoding
RA pathway components is expanded
dorsally in the CMZ of gdf6a mutants.
Lateral views of whole-mount eyes from
32, 48 and 60 hpf embryos showing
expression (purple) of the genes indicated
to the left of the rows. Genes shown
encode enzymes required for RA
synthesis (rdh10a and aldh1a3), a direct
transcriptional target of the RA pathway
(nr2f5), a cytosolic RA-buffering protein
(crabp2a) and an enzyme responsible for
RA catabolism (cyp26a1).
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markers in gdf6a mutants and contributes to CMZ maintenance
during normal development.
Retinal precursors precociously generate neurons in
gdf6amutants
The reduced CMZs in gdf6a mutants could result from changes in
cell cycle kinetics within the CMZ and/or altered timing of cell
cycle exit and transition of post-mitotic cells into the mature retina.
To distinguish between these possibilities, all S-phase cells were
first labelled with BrdU for 4 h prior to fixation. Next, BrdU
incorporation in cells that had progressed to M phase (PH3+) was
evaluated. Wild-type progenitors can progress from S-phase to M-
phase in as little as 2.5 h (Cerveny et al., 2010), and so this labelling
regime results in 100% of PH3+ cells being labelled by BrdU. In
both wild-type sibling and gdf6au768 mutant eyes, we found that all
PH3+ cells were also BrdU+ (Fig. 6A,B; n=16 eyes), suggesting
that cell cycle kinetics were not dramatically changed in mutant
CMZ.
RPCs exit the cell cycle and differentiate in a stereotypical
pattern (Cepko et al., 1996; Harris, 1997), with proliferative RPCs
ultimately restricted to the CMZ by ∼2.5 dpf (Stenkamp, 2007).
To gauge the balance between proliferation and differentiation
after the onset of retinal neurogenesis in gdf6a mutants, we
labelled all S-phase cells with BrdU for 10 h beginning at
∼50 hpf. With this labelling regime, only a small proportion of
cells in wild-type eyes (primarily RGCs) are BrdU negative and
are likely to have exited the cell cycle prior to BrdU treatment
(Fig. 6C, red cells; Ohnuma et al., 1999). By contrast, all layers of
gdf6a mutant retinae contained a much larger proportion of BrdU-
negative cells (Fig. 6D, white arrows). We observed this striking
pattern of precocious cell cycle exit and differentiation in all
embryos (n=60 total genotyped embryos; 14 gdf6au768 mutants).
These data indicate that the pace of neurogenesis is accelerated in
gdf6a mutant retinae.
To characterise the precocious production of neurons in gdf6a
mutants, we analysed the onset and progression of expression of
atoh7 and crx, which both exhibit dynamic, fan-shaped ventral-
nasal to dorsal-temporal patterns of expression (Masai et al., 2000;
Neumann and Nuesslein-Volhard, 2000; Shen and Raymond,
2004). By ∼28 hpf, atoh7 is expressed in a small patch of ventral
RPCs in wild-type eyes (Fig. 6E) whereas a larger proportion of
ventral and central RPCs express atoh7 in gdf6a mutant eyes
(Fig. 6F). Likewise, expression of crx, which is initially transcribed
in the ventral-nasal and ventral-central retina at∼36 hpf in wild-type
eyes (Fig. 6G), is more broadly expressed in gdf6a mutant
eyes (Fig. 6H), similar to wild-type crx expression at 48 hpf
(compare Fig. 6H and 6I). Quantitative PCR in gdf6au900 mutant
retinas corroborated the upregulation of atoh7 and crx (1.5- and
2-fold greater, respectively), as well as of the RA-target gene nr2f5
(2.5-fold greater) (Fig. 6K).
Fig. 4. Pharmacological activation of the RA pathway in wild-type embryos mimics the gdf6a mutant eye phenotype. (A,B). Representative lateral
views of maximum intensity projections of eyes from Tg[RARE:YFP] embryos immunostained for GFP (RARE:YFP, green) and counterstained with DAPI (red).
Eyes are from embryos that were incubated in vehicle control (DMSO; A) or in 13-cis RA (B), exposed to a pulse of UV light, and then fixed and immunostained at
33 hpf. The majority of RPCs in B have responded to RA by activating the RARE:YFP transgene. (C-H) Lateral views of eyes from wild-type embryos treated with
vehicle (DMSO; C,E,G) or the RAR agonist AM580 (25 nM; D,F,H) from 24 to 36 hpf and analysed at 60 hpf for expression of CMZ genes col15a1b (C,D), ccnd1
(E,F) and atoh7 (G,H). (I-L) Representative lateral views of maximum intensity projections of 60 hpf embryonic eyes immunostained for PH3. Eyes from an
untreated sibling and untreated gdf6au768mutant (I and J, respectively) and from aDMSO-treatedwild type and anAM580-treatedwild type (K and L, respectively)
are shown. (M) Graph quantifying PH3+ cells in I-L. The average number of PH3+ cells per retina (n=10 embryos) was calculated and then plotted with standard
error bars (95% confidence limits; pair-wise comparisons using Student’s t-test, ***P≤0.0001).
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To explore the dynamic production of atoh7-positive neurons in
gdf6amutants, we imaged livingTg[atoh7:GFP] embryos. Initiation
of GFP fluorescence occurred at the same time in gdf6au900 mutants
and siblings (Fig. 6L,M, top panels), but the number of GFP-
expressing cells increased more rapidly and RGC axons extended
earlier in mutant retinae (Fig. 6L,M, lower panels; Movies 1, 2),
supporting the idea of expedited differentiation in gdf6a mutants.
Precocious RA-mediated differentiation depletes retinal
progenitors
Because RA pathway activity is enhanced in gdf6a mutant retinae,
we examined whether RA could modulate cell cycle exit and
neurogenesis of RPCs by pharmacologically activating or inhibiting
RA signalling and then examining atoh7 and Tg[atoh7:GFP]
expression. Similar to gdf6a mutant retinae, wild-type embryos
incubated in AM580 exhibited significantly more atoh7+ cells
(Fig. 7A-F). At 28 hpf, ∼2% of the wild-type retinal volume was
GFP+, whereas it was more than doubled in both gdf6a mutant and
AM580-treated wild-type retinae (Fig. 7C,D,K). By 40 hpf, 3% of
wild-type retinal volume was GFP+, but this percentage was nearly
tripled in mutant or AM580-treated wild-type eyes (Fig. 7E,F,K).
Pair-wise t-tests (n=5 for each condition and genotype) indicate that
AM580-treated wild-type and gdf6au768DMSO-treated eyes are not
statistically different from one another at 28 hpf (P=0.188) or at
40 hpf (P=0.77) and that both are different from DMSO-treated
wild-type sibling eyes at both developmental stages (28 hpf:
P=0.017 for DMSO-treated u768 mutants versus DMSO-treated
wild type, P=0.012 for AM580-treated wild type versus DMSO-
treated wild type; 40 hpf: P=0.000003 for DMSO-treated u768
mutants versus DMSO-treated wild type, P=0.0001 for AM580-
treated wild type versus DMSO-treated wild type).
Reducing RA signalling in gdf6a mutants with the RAR
antagonist BMS614 decreased the number of GFP+ cells
(Fig. 7G-J) such that DMSO-treated siblings and BMS614-treated
gdf6au768 embryos contained nearly equivalent GFP+ retinal
volumes (Fig. 7G-J,L). Pair-wise t-tests (n≥7 for each condition
and genotype) indicate that BMS614-treated gdf6au768 and DMSO-
treated sibling eyes contain GFP+ retinal volumes that are not
statistically different from each other at 28 hpf (P=0.566) and 40 hpf
(P=0.229). At 28 hpf, ∼1.5% of the gdf6au768 retinal volume was
GFP+, similar to DMSO-treated siblings and less than that of
gdf6au768 untreated eyes (Fig. 7G-H,L; P=0.07 for BMS614-treated
u768mutants versus DMSO-treated u768mutants). By 40 hpf, both
BMS614-treated gdf6au768 mutant eyes and DMSO-treated sibling
eyes contained similar GFP+ retinal volumes whereas DMSO-
treated gdf6au768 mutant eyes contained substantially larger GFP+
retinal volumes (Fig. 7I,J,L; P=0.001 for BMS614-treated u768
mutants versus DMSO-treated u768 mutants).
Further suggesting that precocious neurogenesis underlies the
gdf6amutant phenotype, we found that mutant eyes contain a higher
proportion of GFP+ neurons in the RGC layer by 80 hpf (Fig. 7M-O;
Fig. S6) and more GFP+ cells in the inner nuclear layer, suggesting
that more atoh7-positive cells are generated earlier (Fig. 7N, white
arrows). Together, these observations suggest that RA can promote
cell cycle exit and the production of atoh7-positive neurons in
developing retinae.
DISCUSSION
This study reveals that opposing activities of Gdf6a from the
dorsal retina and RA from the ventral retina influence RPCs as
they transition from proliferation to differentiation, ultimately
regulating eye size. Our data demonstrate that in addition to
previously demonstrated roles in DV patterning, the combined
action of these pathways regulates when RPCs exit the cell cycle.
Our genetic and pharmacological manipulations illustrate that
Gdf6a-mediated inhibition of RA pathway activity modulates
the timing of retinal neurogenesis and suggest that RA-
mediated precocious differentiation of the RPC pool might
underlie the microphthalmic phenotype in vertebrates carrying
GDF6 mutations.
Gdf6a regulates retinal growth
Our study adds to others linking eye defects to abrogation of Gdf6
function in fish, mice and humans (Asai-Coakwell et al., 2007,
2013; den Hollander et al., 2010; Gosse and Baier, 2009; Hanel and
Hensey, 2006), but the mechanisms connecting loss of gdf6a to
microphthalmia have remained unclear. It has been suggested that
apoptosis contributes to the small eye phenotype in gdf6a mutants
(den Hollander et al., 2010; Gosse and Baier, 2009). Our study
and another (French et al., 2013), provide evidence that
microphthalmia occurs independently of cell death in gdf6a
mutants. Pronounced differences in eye size are observed in
Fig. 5. Pharmacological inhibition of the RA pathway partially rescues the gdf6amutant CMZ phenotype. (A-F) Lateral views of eyes from 60 hpf gdf6au768
mutants treated with vehicle (DMSO;A,C,E) or the RAR inverse agonist BMS493 (15 µM; B,D,F) showing expression of col15a1b (A,B), ccnd1 (C,D) and atoh7
(E,F). The number of embryos with staining pattern similar to that shown is indicated as a fraction in lower right corner of images. (G) qPCR quantification of relative
gene expression levels for col15a1b, ccnd1, atoh7 and nr2f5 in 60 hpf mutant eyes and eyes frommutants treated with BMS493, normalised to β-actin. Values for
each gene from DMSO-treated mutant eyes were set to 1 and fold changes in BMS493-treated eyes were plotted relative to this value (±s.e.).
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gdf6au768 mutants, which exhibit levels of retinal apoptosis
comparable to wild type, and in gdf6au900 embryos when
apoptosis is blocked. Despite these differences in apoptosis, both
gdf6a alleles exhibit similar changes in gene expression,
proliferation and differentiation. Moreover, analyses of gdf6au768
mutants suggest that abnormal initiation of retinal DV patterning is
not a prerequisite for gdf6a-linked microphthalmia.
Gdf proteins regulate cell cycle exit and differentiation
through various mechanisms
Members of the BMP family regulate cell fate, proliferation,
differentiation, and apoptosis during embryonic development. As a
result, BMPs and their antagonists have been implicated in control
of tissue and organ size (Beites et al., 2009; Sartori et al., 2013). The
presence of fewer proliferating cells and the accelerated expression
of differentiation genes in the early retinae of gdf6amutants suggest
that the BMP-related protein Gdf6a is part of a genetic circuit that
balances progenitor cell proliferation and differentiation to control
eye size in zebrafish. In mammals, GDF11 and GDF8 (MSTN)
balance proliferation and differentiation in different contexts. Both
act as auto-inhibitory feedback signals to directly and reversibly
regulate cell cycle exit of neuronal progenitors in the olfactory
epithelium (Wu et al., 2003) and myoblasts (McPherron and Lee,
1997), respectively. GDF11 also modulates retinal size in mice but
Fig. 6. gdf6a mutant retinae exhibit
accelerated differentiation of neurons.
(A,B) Transverse cryosections of retinae from
sibling (A) and gdf6au768 (B) embryos injected
with BrdU twice at 56 hpf, again at 58 hpf, and
then fixed at 60 hpf and immunostained for
markers of DNA replication (BrdU, red) and
G2/M phase (PH3, green). Dashed lines
demarcate the lens and retinal boundaries.
White arrows point to double-labelled cells.
(C,D) Transverse cryosections of retinae from
sibling (C) and gdf6au768 (D) embryos injected
with BrdU at 50 hpf, fixed at 60 hpf, and then
immunostained for BrdU (green) and
counterstained with SYTOX Orange (red).
White arrows point to regions where neurons
were postmitotic at the time of BrdU incubation;
in the wild-type eye, these are restricted mostly
to the RGC layer but are more widely present in
the mutant eye. (E-J) Lateral view of whole-
mount eyes from sibling and mutant embryos
showing expression (purple) of atoh7 at 28 hpf
(E,F), and crx at 36 hpf (G,H) and 48 hpf (I,J).
(K) Real-time PCR quantification of atoh7, crx
and nr2f5 expression from 28 hpf dissected
mutant and wild-type retinas normalized to
β-actin. Wild-type values for each gene were
set to 1 and mutant fold changes were plotted
relative to this value (±s.e.). (L,M) Maximum
intensity projections at single time points from
time-lapse analyses of the generation of
Tg[atoh7:GFP]-positive RGCs in wild-type (L)
and gdf6a mutant (M) eyes. Stacks (80 µm) of
2-µm optical sections were captured every
18 min for 9 h from 28.5 hpf (t=0). Nuclei are
labelled with histone H2B-mcherry (red). See
also Movies 1 and 2. Time (t) is in minutes.
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through a different mechanism. During early neurogenesis,
expression of GDF11 and its inhibitor, follistatin, influence the
timing of expression of Atoh7 (also known as Math5) without
affecting expression of cell cycle regulators (Kim et al., 2005).
Despite diverse mechanisms by which these GDF proteins act, they
promote similar consequences for timing of cell cycle exit and
differentiation.
Gdf6a-antagonised RA pathway activity regulates cell cycle
exit and differentiation
Our study reveals that a key role for Gdf6a is to limit RA activity in
RPCs. We show that enhancing RA activity accelerates the
production of neurons from RPCs and this presumably depletes
the pool of proliferative precursors. Such a role for RA is consistent
with studies showing that RA promotes neuronal differentiation in
vitro (reviewed by Janesick et al., 2015). In the vertebrate retina, RA
can skew the fate of post-mitotic photoreceptor precursors towards
rod and red-sensitive cone fates (Hyatt et al., 1996; Kelley et al.,
1999; Mitchell et al., 2015; Stevens et al., 2011) and in vitro studies
of oligodendrocyte precursors suggest that the timing of
differentiation is modulated by retinoid signalling (Barres et al.,
1994). Similarly, our data indicate that RA influences the timing of
cell cycle exit and neuronal differentiation in the developing central
retina and CMZ. Consequently, unlike other Gdfs that regulate
timing of neurogenesis by promoting cell cycle exit (Gokoffski
et al., 2011; Kim et al., 2005; Wu et al., 2003), our data suggest that
Gdf6a is permissive for proliferation and, in balance with RA
signalling, governs the timing of differentiation in the retina to
preserve the pool of progenitors needed for multiple rounds of
neurogenesis.
Although our data suggest that antagonism between Gdf6a and
RA regulates RPC behaviours, Gdf6a could also interact with other
signalling pathways to influence proliferation and differentiation.
For instance, Fgf signalling maintains a subpopulation of RPCs in a
proliferative state (Wong et al., 2015), and Hedgehog signalling is
implicated in RPC proliferation and differentiation decisions
(Borday et al., 2012; Locker et al., 2006; Masai et al., 2000).
Cross-talk and integration between these pathways and BMP have
been demonstrated in many diverse progenitor cell populations,
including those in the developing neural tube (e.g. Horner and
Caspary, 2011; Sasai et al., 2014).
Intersection between morphogenetic and neurogenic
effects of Gdf6a
In addition to the requirement for Gdf6a to establish and maintain
dorsal retinal character, we suggest an additional role for Gdf6a
during eye development. Our data suggest that Gdf6a modulates RA
pathway activity, which in turn influences the probability of RPC
Fig. 7. RA pathwayactivation accelerates
retinal neurogenesis. (A-F) Lateral views
of eyes of wild-type (A,B) or Tg[atoh7:GFP]
(C-F) embryos treated with AM580 (B,D,F)
or vehicle control (DMSO; A,C,E) fixed at
the times indicated to the left of the rows,
and showing expression of either atoh7
(purple; A,B) or immunostained for GFP
(green; C-F). (G-J) Lateral views of eyes of
gdf6au768 mutants expressing the atoh7:
GFP transgene treated with BMS614 (H,J)
or vehicle control (DMSO; G,I), fixed at the
times indicated to the left of the rows, and
immunostained for GFP (green). Note that
GFP expression does not extend beyond its
ventronasal initiation site in the BMS614-
treated eye at 28 hpf. (K,L) Graphs showing
average proportional volume of retina
containing atoh7:GFP-positive cells at 28
and 40 hpf in the conditions indicated along
the x-axes for activation (K) and
suppression (L) of RA pathway, plotted with
standard error bars (95% confidence limits;
n=5 embryos for each condition). (M,N)
Transverse cryosections of wild-type sibling
(M) and gdf6au900 (N) eyes at 80 hpf
showing expression of the atoh7:GFP
transgene (green) and counterstained
nuclei with DAPI (red). White arrows show
ectopic GFP-positive cells in the inner
nuclear layer. (O) Graph of the average
number of atoh7:GFP-positive cells per
area of retina in wild-type and gdf6au900
mutant eyes (n=6; standard error bars,
95% confidence limits; Student’s t-test
**P=0.0014).
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cell cycle exit by regulating proliferative versus neurogenic
divisions. Bolstering this idea, we observed enhanced and
accelerated expression of the bHLH transcription factor-encoding
gene atoh7, which is required for RGC production (Kay et al.,
2001). Furthermore, we show that normal timing of atoh7
expression is restored when RA pathway activity is downregulated
in gdf6a mutants. Two observations from studies in medaka fish
also support a connection between RA, atoh7 expression, and eye
size. First, a global analysis of the regulatory inputs driving retinal
neurogenesis identified a potential positive role for RA upstream of
atoh7 expression (Souren et al., 2009), and, second, a study that
expanded atoh7 expression throughout the developing retina
generated smaller eyes (Sinn et al., 2014).
How might an imbalance between RA and Gdf6a contribute to
the small eyes in gdf6a mutants? We observe a smaller CMZ in
mutant eyes as well as in eyes in which the RA pathway is activated
early in development. Consequently, the failure of gdf6a eyes to
grow robustly could be due to problems in both establishment of the
CMZ and generation of neurons from the CMZ. Although studies
have begun to examine the origins of the CMZ (Heermann et al.,
2015; Kwan et al., 2012), how this stem cell niche is established and
maintained is not clear. One possibility is that in gdf6a mutants,
precocious differentiation of RPCs depletes the pool of progenitors
that ultimately populate the CMZ, thus generating a smaller CMZ.
Coupled with the possibility of fewer stem and progenitor cells in
theCMZofgdf6amutants, defectiveGdf6a/retinoid signallingwithin
the CMZ is likely to further limit eye growth by exhausting the stem
cell/progenitor population.Manysignalling pathways required during
early eye development, including BMP and RA pathways, remain
active within the CMZ (Harris and Perron, 1998; Sharma et al., 2005;
Shawi and Serluca, 2008). Previous work from our laboratories
supports a model for differentiation dynamics within the zebrafish
CMZ with at least two sets of environmental signals coexisting. One
set of signals promotes proliferation of stem and progenitor cells and
the other limits proliferation of rapidly cycling precursors by
encouraging differentiation (Cerveny et al., 2010). Although a
molecular basis for this so-called ‘environmentally driven
differentiation’ has yet to be established, our current work suggests
that Gdf6a and RA are two secreted signals that establish an
appropriate balance between proliferation and differentiation in the
CMZ. Together, our results support a model in which dorsally
secreted Gdf6a balances RA pathway activity, controlling the
transition from proliferation to differentiation during eye growth.
MATERIALS AND METHODS
Zebrafish lines
Eggs were collected by natural spawning, raised at 28.5°C in either fish
water or E3 embryo medium (Nüsslein-Volhard and Dahm, 2002) and
staged according to Kimmel et al. (1995). Transgenic and mutant lines are
listed in supplementary Materials and Methods. To prevent pigment
formation, 0.003% phenylthiourea (PTU, Sigma) was added to the fish
water between 20 and 24 hpf.
ENU mutagenesis and eye screening
Mutagenesis was performed in wild-type male AB/TL fish by four rounds of
3 mM ENU treatment as previously described (Valdivia et al., 2011; van
Eeden et al., 1999). Eyes of F3 larvae were screened for morphological
abnormalities.
Genetic mapping, cloning and genotyping
The gdf6au768mutation was mapped by bulk segregant analysis with simple
sequence length polymorphisms to LG16 (Talbot and Schier, 1999).
Markers Z13555 and Z45043 flanked a ∼2 Mb interval containing gdf6a.
gdf6au768 carriers were crossed to a reported gdf6a mutant line (rdrs327;
Gosse and Baier, 2009) for complementation testing. The gdf6au900
mutation was in turn complementation tested with gdf6au768. To identify
the molecular nature of both mutations, we performed RT-PCR
(SuperScript-II Reverse Transcriptase and random primers; Invitrogen) on
RNA isolated from 3 dpf wild-type and gdf6au768 larvae (Trizol,
Invitrogen), and PCR on genomic DNA obtained using the HotSHOT
method (Meeker et al., 2007) for gdf6au900. Amplicons were cloned into
TOPO-TA vectors (Invitrogen) for sequencing. Oligonucleotides for
cloning, sequencing and genotyping are listed in supplementary Materials
and Methods.
Microinjections
Capped histone H2B-red fluorescent protein fusion (H2B-RFP) mRNAwas
prepared using the mMessage mMachine RNA Synthesis Kit (Ambion)
according to the manufacturer’s instructions. One-cell-stage embryos
resulting from gdf6au900 heterozygous in-crosses carrying the Tg[atoh7:
GFP]cu2 transgene were injected with 150 pg of mRNA.
Histology
To prepare in situ hybridisation probes, DNA templates were generated by
restriction digestion of plasmids carrying atoh7, ccnd1, cdkn1c, nr2f5,
aldh1a2, aldh1a3 and cyp26a1 or by PCR from cDNA for col15a1b,
crabp2a and rdh10a. For each template, the reverse strand oligonucleotide
encodes a T3 polymerase priming site as well as the gene-specific sequence
(Thisse and Thisse, 2008). All primers are provided in supplementary
Materials andMethods. Digoxigenin-labelled RNA probes were transcribed
using a DIG labelling kit (Roche) with the appropriate polymerases
(Promega or NEB). Embryos were processed as previously described
(Thisse and Thisse, 2008) and hybridisation signals were detected with anti-
digoxigenin-AP antibody (1:3000; 11093274910, Roche) and NBT/BCIP
substrate (1:3.5; Roche).
Apoptotic cell death was detected by terminal deoxynucleotidyl
transferase-mediated dUTP nick end labelling (TUNEL). Embryos were
fixed in 4% paraformaldehyde overnight and kept in methanol 100% until
used. Following rehydration, embryos were treated following
manufacturer instructions using the ApopTag kit (Millipore). An anti-
digoxigenin-AP antibody (1:3000; Roche) was used for NBT/BCIP
(Roche) detection.
For sectioning, embryos were fixed with 4% paraformaldehyde overnight
at 4°C and then cryoprotected by sequential incubation in 15% and 30%
sucrose dissolved in PBS supplemented with 0.5% Triton X-100 (PBST) for
12-16 h at 4°C. They were embedded in OCT, frozen on dry ice, and
sectioned at 16-25 µm using a Leica cryostat. All immunostaining steps
were performed at room temperature (∼22°C).
BrdU incorporation was performed at room temperature as previously
described (Cerveny et al., 2010). Briefly, 1 nl pulses of 10 mg/ml BrdU in
E3 were injected into the hearts of embryos anaesthetised with MS-222 and
immobilised in 1% low melting point agarose dissolved in E3. After
injection at defined time points, embryos were liberated from agarose and
incubated in E3 until fixation with 4% paraformaldehyde.
Primary antibodies used were: chicken or mouse anti-GFP (ab13970 and
ab1218, Abcam; 1:1000); rabbit anti-RFP (PM005, Medical & Biological
Laboratories Co.; 1:2500); mouse anti-BrdU (3262F, Millipore; 1:200);
rabbit anti-PH3 (06-570, Millipore; 1:400).
Microscopy and image analysis
After in situ hybridisation or before immunostaining, embryo tails
were genotyped and heads and/or dissected eyes were either imaged
using a Nikon E1000 microscope equipped with DIC 20×0.5 NA and
40×1.15 NA objective lenses or subjected to immunohistochemistry. After
immunohistochemistry or for time-lapse imaging of transgenic lines,
sections or agarose-embedded embryos were imaged with Leica SPE
(25×0.95 NA and 40×0.8 NA water immersion objectives) or Nikon A1+
(25×1.1 NA water immersion objective) confocal microscopes.
Digital images were processed with ImageJ and/or Imaris (Bitplane)
software and compiled using Photoshop CS6 (Adobe). For some images,
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white balance was digitally adjusted using the exposure option in Photoshop
CS6. For quantifying TUNEL+, PH3+ and PH3+/BrdU+ cells, images were
blind-counted using ImageJ. To quantify the volume of retinae containing
GFP+ cells, the fluorescence of each z-plane of confocal stacks (∼60 µm)
was thresholded, images compiled and a contour surface drawn for both the
entire eye and the fluorescent portion using the surface contour feature
and either manual selection (for the entire eye) or auto selection (for
GFP fluorescence) of Imaris. For eye and section size measurements,
images taken from a lateral view at fixed magnification were opened in
ImageJ. The freehand selection tool was used to select to outline the
circumference of each eye and then the measure function was used to
calculate the area. Data were exported to R or Prism (GraphPad) for
statistical analysis and graphing. Either permutation testing with 10,000
shuffles or Student’s t-tests with 5% cut-offs were used as indicated in the
Results and figure legends. See supplementary Materials and Methods for
details of permutation testing.
Time-lapse imaging
Confocal time-lapse imaging was performed on a Leica SP8 confocal
microscope in an air chamber heated to 28.5°C. Once anaesthetised with
MS-222 (Sigma), embryos were immobilised in 1.2% low melting point
agarose (Sigma) and imaged from a lateral view using water immersion
objectives. Z-stacks were collected at intervals of 20 min for 9 h, beginning
at 28.5 hpf.
Pharmacological manipulation of apoptotic or RA pathways
To block apoptosis, embryos were incubated with either 200 or 400 µM of
the pan-caspase inhibitor Z-VAD-FMK (Promega) from 14 to 31 hpf
(Williams et al., 2000). The drug was washed out and embryos were either
fixed or incubated in fish water until 3 dpf and then fixed.
To activate RA pathway activity, embryos were soaked in 25 nM
AM580 (Sigma), a pan-retinoic acid receptor (RAR) agonist, beginning at
24 hpf for the times indicated in figure legends. To inhibit the pathway,
embryos were soaked in either 15 µM BMS493 (Sigma), an RARα inverse
agonist, or 15 µM BMS614 (Tocris), an RARα antagonist, for 14-36 h
from the 12-14 somite stage, which is after initial dorsal-ventral patterning
of the eye and brain. After drug treatments, embryos were washed twice
with embryo medium and then incubated until fixation with 4%
paraformaldehyde at 28, 40 or 60 hpf. For optical manipulation of RA
activity in the retina, Tg[RARE:YFP]id1 embryos were soaked in 5 nM 13-
cisRA (Sigma; Xu et al., 2012) at 24 hpf for 1 h in the dark and then
mounted in 1.2% low melting point agarose. Photoactivation was
performed with a single pulse of UV light (360-375 nm) illuminating the
eye for 30 s, using a Zeiss 510 NLO two-photon microscope with 5 mW of
power. Embryos were fixed at 33 hpf in 4% paraformaldehyde and
immunostained for GFP.
Quantitative real-time PCR
Quantitative RT-PCR was performed with total RNA extracted from
dissected fixed retinae at 28 hpf and 3 dpf. Briefly, embryos were fixed in
4% paraformaldehyde overnight and transferred to RNAse-free PBS, after
two washes for 5 min each. Embryo tails were genotyped using KASP
assays (Kettleborough et al., 2013). Heads were pooled by genotype and
retinae dissected manually using insect pins. RNA was extracted using
RecoverAll Total Nucleic Acid Isolation Kit for FFPE (Ambion) from 40
retinas for each condition (wild-type sibling versus mutant at each time
point). RNA quality control was performed with the Experion LabChip
(Bio-Rad). cDNAwas synthesised and amplified with the Transplex Whole
Transcriptome Amplification Kit (Sigma), and quantified using a Nanodrop
2000c. Quantitect primers (Qiagen) were used to amplify col15a1b
(QT02215941), ccnd1 (QT02178519), atoh7 (QT02188459), nr2f5
(QT02125424), aldh1a3 (QT02111613), crx1 (QT02229584), cdkn1c
(QT02052253) and β-actin (QT02174907). Real-time PCR was
performed on a BioRad iCycler using GoTaq qPCR Master Mix
(Promega). Fold change in RNA levels was calculated using the ΔΔCt
method, and expression normalised to β-actin levels (Livak and Schmittgen,
2001).
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